CAMBRIDGE NUTRITIONAL SCIENCES PLC Cambridge Nutritional Sciences plc Stock
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.9 GBX | -1.27% |
|
-2.50% | +62.50% |
| Apr. 22 | Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named | MT |
| Apr. 22 | Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 | CI |
| Sales 2024 * | 9M 11.25M | Sales 2025 * | - | Capitalization | 9.4M 11.75M |
|---|---|---|---|---|---|
| Net income 2024 * | -1M -1.25M | Net income 2025 * | - | EV / Sales 2024 * | 0.58 x |
| Net cash position 2024 * | 4.2M 5.25M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-7.9
x | P/E ratio 2025 * |
-
| Employees | 91 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cambridge Nutritional Sciences plc
More press releases
| 1 day | -1.27% | ||
| 1 week | -2.50% | ||
| Current month | +13.04% | ||
| 1 month | +14.71% | ||
| 3 months | +62.50% | ||
| 6 months | +77.27% | ||
| Current year | +62.50% |
1 week
3.70
4.17
1 month
3.204.17
Current year
2.304.17
1 year
1.664.17
3 years
1.6688.80
5 years
1.66126.95
10 years
1.66126.95
| Managers | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Jeremy Millard
BRD | Director/Board Member | 53 | 19-02-28 |
Carolyn Rand
CHM | Chairman | 60 | 23-08-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 3.9 | -1.27% | 162 099 |
| 24-04-29 | 3.95 | +2.60% | 1,178,848 |
| 24-04-26 | 3.85 | 0.00% | 623,930 |
| 24-04-25 | 3.85 | -3.75% | 1,184,714 |
| 24-04-24 | 4 | 0.00% | 1,861,453 |
Delayed Quote London S.E., April 30, 2024 at 11:35 am EDT
More quotes
Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +62.50% | 11.8M | |
| -0.60% | 12.95B | |
| -9.59% | 7.84B | |
| +1.82% | 5.5B | |
| +0.02% | 4.61B | |
| +7.55% | 4.61B | |
| -47.84% | 3.4B | |
| +6.42% | 2.66B | |
| -14.59% | 2.08B | |
| +1.78% | 1.79B |
- Stock Market
- Equities
- ODX Stock
